Virginia Regulatory Town Hall
Department of Health Professions
Board of Pharmacy
Regulations Governing Collaborative Practice Agreements [18 VAC 110 ‑ 40]
Action is Exempt from Article 2 of the Administrative Process Act
Implementaton of 2020 legislation
Action 5607
General Information
Action Summary The action will amend the requirements for documented informed consent by a patient for participation in a collaborative practice agreement between a prescriber and a pharmacist. The amendment will conform to changes made in HB1506 of the 2020 General Assembly that specifies a patient must opt out of participation rather than signing a document for consent to such an agreement.
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: ยง 2.2-4006 (A) (4)(a)
RIS Project Yes  [006506]
Associated Mandates Collaborative practice agreements
New Periodic Review This action will be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
9078 Final Stage complete. This regulation became effective on 11/25/2020.
Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address:
Phone: (804)367-4456    FAX: (804)527-4472    TDD: ()-

This person is the primary contact for this chapter.